Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 22, 2024
On Thursday, I delivered testimony before the House Oversight and Accountability Subcommittee on National Security, the Border, and Foreign Affairs at a hearing titled “Accountable Assistance: Reviewing Controls to Prevent Mismanagement of Foreign Aid.” I argued that the financial flow of assistanc...
TESTIMONY
March 21, 2024
On Thursday, March 21, 2024, CGD Senior Fellow Charles Kenny appeared before the Subcommittee on National Security, the Border, and Foreign Affairs of the House Committee on Oversight and Accountability at a hearing titled “Accountable Assistance: Reviewing Controls to Prevent Mismanagement of Forei...
Blog Post
March 19, 2024
oughly, six percent of health allocations are estimated to be siphoned away through corruption. Health systems are particularly vulnerable to corruption because of the complex nature of the provision of health care, information asymmetries and financial fragmentation. To advance progress toward UHC,...
Blog Post
May 02, 2023
In an attempt to curtail corruption countries have implemented public sector reforms to increase the wages of government officials. However, the evidence on the effectiveness of such interventions on corruption is mixed. In a recent paper, we find that differences in public sector wage inequality pl...
WORKING PAPERS
May 02, 2023
Wage inequality in the public sector is an important determinant of the effectiveness of anti-corruption policies. Increasing the wages of public officials could help reduce corruption in countries with low public sector wage inequality, but in countries where public sector wages are highly unequal,...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...